Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 3, 2013, Pages 322-329

  McConville, Christopher ^a   Friend, David ^b  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Antiretroviral; HIV; SMEDDS; UC781; Vaginal capsule

Indexed keywords

GELATIN; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; HYDROPHOBICITY; POWDER; SELFMICROEMULSIFYING DRUG DELIVERY SYSTEM;

ANILIDES; ANTI-HIV AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; EMULSIONS; FEMALE; FURANS; HUMANS; SOLUBILITY;

EID: 84875226786     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.10.007     Document Type: Article

References (40)

1. J. Richardson, and L. Illum The vaginal route of peptide and protein drug delivery Adv. Drug Deliv. Rev. 8 1992 341 366
2. T. Mukherjee, and F.M. Plakogiannis Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole J. Pharm. Pharmacol. 62 2010 1112 1120
3. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 2007 645 666
4. Y. Miyako, N. Khalef, K. Matsuzaki, and R. Pinal Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect Int. J. Pharm. 393 2010 48 54
5. J. Millard, F. Alvarez-Núñez, and S. Yalkowsky Solubilization by cosolvents. Establishing useful constants for the log-linear model Int. J. Pharm. 245 2002 153 166
6. A.T.M. Serajuddin Salt formation to improve drug solubility Adv. Drug Deliv. Rev. 59 2007 603 616
7. D. Fleisher, R. Bong, and B.H. Stewart Improved oral drug delivery: solubility limitations overcome by the use of prodrugs Adv. Drug Deliv. Rev. 19 1996 115 130
8. D. Singhal, and W. Curatolo Drug polymorphism and dosage form design: a practical perspective Adv. Drug Deliver. Rev. 56 2004 335 347
9. N. Blagden, M. de Matas, P.T. Gavan, and P. York Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates Adv. Drug Deliv. Rev. 59 2007 617 630
10. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42
11. C.W. Pouton Formulation of self-emulsifying drug delivery systems Adv. Drug Deliv. Rev. 25 1997 47 58
12. H. Shen, and M. Zhong Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin J. Pharm. Pharmacol. 58 2006 1183 1191
13. J. Kovarik, E. Mueller, J. Bree, W. Tetzloff, and K. Kutz Reduced inter- and intraindividual variability in cyclosporin pharmacokinetics from a microemulsion formulation J. Pharm. Sci. 83 1993 444 446
14. C. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 2000 S93 S98
15. A. Attama, and M. Nkemnele In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus Int. J. Pharm. 304 2005 4 10
16. J.Y. Kim, and Y.S. Ku Enhanced absorption of Indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats Int. J. Pharm. 194 2000 81 89
17. K. Takada, M. Murakami, Glycyrrhizin Preparations for Transmucosal Absorption, US Pat 6890547.
18. J. Balzarini, and E. De Clercq The thiocarboxanilides UC-10 and UC-781 have an additive inhibitory effect against human immunodeficiency virus type 1 reverse transcriptase and replication in cell culture when combined with other antiretroviral drugs Antivir. Chem. Chemother. 8 1997 197 204
19. G.F. Vanhove, J.M. Gries, D. Verotta, L.B. Sheiner, R. Coombs, A.C. Collier, and T.F. Blaschke Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapy Antimicrob. Agents Chemother. 41 1997 2433 2438
20. S. Vella, and M. Floridia Saquinavir-clinical pharmacology and efficacy DRUGS 34 1998 189 201
21. F. Hoffmann-La Roche Ltd., Basel, Switzerland. Fortovase® (Saquinavir), Product monograph, 1998.
22. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
23. C. Herrera, N. Armanasco, P. Fletcher, J. Nuttall, J. Romano, R. Shattock, Combinations of maraviroc and reverse transcriptase inhibitors as potential microbicides, in: 2010 International Microbicides Conference, Pittsburgh, abstract 22, 2010.
24. A. Evans, Protease inhibitors darunavir, lopinavir and ritonavir as potential microbicides, in: 2010 International Microbicides Conference, Pittsburgh, abstract 24, 2010.
25. M. Stefanidou, Evaluation of saquinavir as a candidate microbicide compound in cellular and mucosal tissue models of HIV-1 infection, in: 2010 International Microbicides Conference, Pittsburgh, abstract 115, 2010.
26. Q. Abdool Karim, S.S. Abdool Karim, J.A. Frohlich, A.C. Grobler, C. Baxter, L.E. Mansoor, A.B. Kharsany, S. Sibeko, K.P. Mlisana, Z. Omar, T.N. Gengiah, S. Maarschalk, N. Arulappan, M. Mlotshwa, L. Morris, and D. Taylor CAPRISA 004 Trial Group, effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science 329 2010 1168 1174
27. E. Aubeny, J.C. Colau, and A. Nandeuil Local spermicidal contraception: a comparative study of the acceptability and safety of a new pharmaceutical formulation of benzalkonium chloride, the vaginal capsule, with a reference formulation, the pessary Eur. J. Contracept. Reprod. Health Care 5 2000 61 67
28. A.M. Nel, L.B. Mitchnick, P. Risha, L.T. Muungo, and P.M. Norick Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women J. Womens Health 20 2011 1207 1214
29. R.K. Malcolm, K.L. Edwards, P. Kiser, J. Romano, and T.J. Smith Advances in microbicide vaginal rings Antiviral Res. 88 2010 S30 S39
30. G. Venkatesh, M.I.A. Majid, S.M. Mansor, N.K. Nair, S.L. Croft, and V. Navaratnam In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone Drug Dev. Ind. Pharm. 36 2010 735 745
31. P. Zhang, Y. Liu, N. Feng, and J. Xu Preparation and evaluation of self-microemulsifying drug delivery system of oridonin Int. J. Pharm. 355 2008 269 276
32. A.K. Singh, A. Chaurasiya, A. Awasthi, G. Mishra, D. Asati, R.K. Khar, and R. Mukherjee Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS) AAPS PharmSciTech 10 2009 906 916
33. M.R. Billany Suspension and emulsion M.E. Aulton, Aulton's Pharmaceutics: The Design and Manufacture of Medicines 2007 Churchill Livingstone Elsevier London 393 394
34. X. Wu, J. Xu, X. Huang, and C. Wen Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability Drug Dev. Ind. Pharm. 37 2011 15 23
35. C. Malcolmson, C. Satra, S. Kantaria, A. Sidhu, and M.J. Lawrence Effect of oil on the level of solubilization of testosterone propionate into nonionic oil-in-water microemulsions J. Pharm. Sci. 87 1 1998 109 116
36. D. Attivi, I. Ajana, A. Astier, B. Demoré, and S. Gibaud Development of microemulsion of mitotane for improvement of oral bioavailability Drug Dev. Ind. Pharm. 36 2010 421 427
37. A.T. Florence, and D. Attwood Physicochemical Principles of Pharmacy 2006 Pharmaceutical Press London pp. 177-228
38. K.C. Ofokansi, K.I. Chukwu, and S.I. Ugwuanyi The use of liquid self-microemulsifying drug delivery systems based on peanut oil/tween 80 in the delivery of griseofulvin Drug Dev. Ind. Pharm. 35 2009 185 191
39. B.S. Lee, M.J. Kang, W.S. Choi, Y.B. Choi, H.S. Kim, and S.K. Lee Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability Arch. Pharm. Res. 32 2009 1629 1635
40. V. Nekkanti, P. Karatgi, R. Prabhu, and R. Pillai Solid self-microemulsifying formulation for candesartan cilexetil AAPS PharmSciTech 11 2010 9 17